EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Xenotransplantation: A Suggested Next Step

David K C Cooper iD, Rita Bottino iD

Xenotransplantation · 2026-05 · 33 (3)

DOI: 10.1111/xen.70133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Xenotransplantation, online erschienen am 21.06.2026. Verfasst von David K C Cooper und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center For Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Kidney Transplantation, Islets of Langerhans Transplantation, Diabetic Nephropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: American Society of Nephrology, U.S. Department of Health and Human Services, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent progress has been made toward introducing gene‐edited (GE) pig heart and kidney xenotransplantation into clinical practice. In particular, the outcomes of GE pig kidney transplantation have been promising, with three recipients currently surviving between 3 and 9 months after transplantation. These encouraging results highlight the growing feasibility of xenotransplantation as a solution to the shortage of human donor organs. In the United States and many other countries, nearly half of all patients on kidney transplant waiting lists are diabetic. Individuals with diabetic nephropathy often achieve better outcomes when they receive both kidney and islet allotransplants, as this combination restores renal function and improves glucose control. Therefore, such patients would be ideal candidates for combined GE pig kidney and islet xenotransplantation. Because immunosuppressive therapy is essential to maintain a kidney graft, performing a simultaneous islet transplant is clinically justifiable. Studies in nonhuman primates have demonstrated that porcine islet transplantation can achieve long‐term glucose regulation, supporting its translational potential. For the foreseeable future, until complications such as post‐transplant proteinuria are fully resolved, we propose that patients with diabetic nephropathy receive a human kidney allotransplant in combination with a GE pig islet xenotransplant to optimize outcomes and improve long‐term metabolic stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousKidney TransplantationIslets of Langerhans TransplantationDiabetic NephropathiesAnimalsHumansSwineHeterograftsGraft SurvivalGraft RejectionAnimals, Genetically Modified

Stichwörter der Autor:innen

allotransplantationdiabetic nephropathyisletskidneyxenotransplantation

Autor:innen und Institutionen

  • Center For Transplantation Sciences, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.
  • Imagine Pharma, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: David K C Cooper, Rita Bottino

Förderung

  • American Society of Nephrology
  • U.S. Department of Health and Human Services
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Cooper, D. K. C., & Bottino, R. (2026). Clinical Xenotransplantation: A Suggested Next Step. Xenotransplantation, 33(3). https://doi.org/10.1111/xen.70133

Vancouver

Cooper DKC, Bottino R. Clinical Xenotransplantation: A Suggested Next Step. Xenotransplantation. 2026;33(3). doi:10.1111/xen.70133

BibTeX
@article{Cooper2026,
  author = {Cooper, David K C and Bottino, Rita},
  title = {Clinical Xenotransplantation: A Suggested Next Step},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {3},
  doi = {10.1111/xen.70133}
}
Kostenlos starten →